gsk plc, RSV and zoster vaccine
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant said Wednesday a Phase 3 study evaluating RSV vaccine Arexvy co-administered with Shingrix met the primary endpoint,
Money Talks News on MSN3d
This Vaccine Is Now Tied to a 17% Lower Dementia RiskGetting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
Shingles is “one of the worst pains in medicine.” A vaccine is highly effective at preventing it, but many people don’t get ...
The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
More Australians will be able to get a free vaccine for the painful condition shingles. Aussies ages 18 to 64 who are classed ...
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...
More than 200,000 Australians will now be eligible for a free shingles vaccinations, as the government expands their ...
reactogenicity and safety of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) when co-administered with SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), both AS01-adjuvanted vaccines ...
More Prince Edward Islanders are now eligible for a free shingles vaccine after the province lowered the age of eligibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback